Women who take estrogen for 10 years or longer after menopause substantially increase their risk of dying of ovarian cancer compared with women who do not take the hormone, according to a study ...

In fact, as insulin is a true gonadotropic hormone that synergizes with the luteinizing hormone (LH) in the regulation of ovarian steroidogenesis; it may amplify ovarian androgen production rates ...

Researchers from the National Cancer Institute (NCI) have found that women in a large study who used estrogen replacement therapy after menopause were at increased risk for ovarian cancer. The ...

Effects of isoliquiritigenin on ovarian antral follicle growth and steroidogenesis. Reproductive Toxicology , 2016; 66: 107 DOI: 10.1016/j.reprotox.2016.10.004 Cite This Page : ...

About 20 million American women take estrogen after ... the American Medical Association found that women who used estrogen for a decade or more were twice as likely to die of ovarian cancer. U ...

The risk increased proportionately with longer duration of hormone use; those who used estrogen therapy for 20 or more years were approximately three times more likely to develop ovarian cancer.

Estradiol is a female sex hormone produced by the ovaries, adrenal gland and also the placenta during pregnancy. Estradiol is the most important hormone during a female’s reproductive years, and ...

[2] Relationships between the antral follicle count, steroidogenesis, and secretion of follicle‐stimulating hormone and anti‐Müllerian hormone during follicular growth in cattle. Reproductive ...

Women under 40 who use estrogen to ease menopause symptoms after having their ovaries removed do not have an increased risk of breast cancer, according to a new study.

The polycystic ovary syndrome (PCOS), one of the most common causes of female infertility, affects approximately 6–8% of women of a reproductive age. The diagnostic criteria of PCOS are currently ...